Investigating the Utility of Demyelination Tracer [18F]3F4AP in Controls and Multiple Sclerosis Subjects
Clinical trial NCT04699747 · RECRUITING
Trial details
- NCT number
- NCT04699747
- Sponsor
- Massachusetts General Hospital
- Status
- RECRUITING
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2021-03-25
- Primary completion
- 2026-11-30
- Enrollment
- 60
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.